182 related articles for article (PubMed ID: 32327529)
1. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
[TBL] [Abstract][Full Text] [Related]
2. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
[TBL] [Abstract][Full Text] [Related]
3. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
4. Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy.
Temsamani J; Bonnafous C; Rousselle C; Fraisse Y; Clair P; Granier LA; Rees AR; Kaczorek M; Scherrmann JM
J Pharmacol Exp Ther; 2005 May; 313(2):712-9. PubMed ID: 15647327
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of analogues of M6G.
Trécant C; Dlubala A; George P; Pichat P; Ripoche I; Troin Y
Eur J Med Chem; 2011 Sep; 46(9):4035-41. PubMed ID: 21689868
[TBL] [Abstract][Full Text] [Related]
6. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
7. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
Faura CC; Olaso JM; Cabanes CG; Horga JF
Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
[TBL] [Abstract][Full Text] [Related]
8. Morphine metabolism, transport and brain disposition.
De Gregori S; De Gregori M; Ranzani GN; Allegri M; Minella C; Regazzi M
Metab Brain Dis; 2012 Mar; 27(1):1-5. PubMed ID: 22193538
[TBL] [Abstract][Full Text] [Related]
9. Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.
Yang L; Fawcett JP; Zhang H; Tucker IG
J Pharm Pharmacol; 2013 Apr; 65(4):561-6. PubMed ID: 23488785
[TBL] [Abstract][Full Text] [Related]
10. Morphine-6-glucuronide: an analgesic of the future?
Lötsch J; Geisslinger G
Clin Pharmacokinet; 2001; 40(7):485-99. PubMed ID: 11510626
[TBL] [Abstract][Full Text] [Related]
11. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
Murthy BR; Pollack GM; Brouwer KL
J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
14. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
Doyle HH; Murphy AZ
Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children.
Verscheijden LFM; Litjens CHC; Koenderink JB; Mathijssen RHJ; Verbeek MM; de Wildt SN; Russel FGM
PLoS Comput Biol; 2021 Mar; 17(3):e1008786. PubMed ID: 33661919
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
Wu D; Kang YS; Bickel U; Pardridge WM
Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
[TBL] [Abstract][Full Text] [Related]
17. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
Klimas R; Mikus G
Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
[TBL] [Abstract][Full Text] [Related]
18. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of morphine-6-glucuronide (M6G) for postoperative pain relief: a randomized, double-blind study.
Smith TW; Binning AR; Dahan A
Eur J Pain; 2009 Mar; 13(3):293-9. PubMed ID: 18550399
[TBL] [Abstract][Full Text] [Related]
20. Dynamic medicinal chemistry in the elaboration of morphine-6-glucuronide analogs.
Cashman JR; MacDougall JM
Curr Top Med Chem; 2005; 5(6):585-94. PubMed ID: 16022681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
